Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy

Por Demetri, G D
Publicado em 2001

Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.

Por Singer, S, Corson, J M, Demetri, G D, Healey, E A, Marcus, K, Eberlein, T J
Publicado em 1995

Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.

Por Demetri, G D, Ernst, T J, Pratt, E S, Zenzie, B W, Rheinwald, J G, Griffin, J D
Publicado em 1990

Phase II SWOG-directed Intergroup Trial (S0505) of Sorafenib in Advanced Soft Tissue Sarcomas

Por von Mehren, M., Rankin, C., Goldblum, J.R., Demetri, G.D., Bramwell, V., Ryan, C.W., Borden, E.
Publicado em 2011

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

Por Cesne, A L, Judson, I, Maki, R, Grosso, F, Schuetze, S, Mehren, M V, Chawla, S P, Demetri, G D, Nieto, A, Tanovic, A, Blay, J-Y
Publicado em 2013

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

Por Ganjoo, K. N., Villalobos, V. M., Kamaya, A., Fisher, G. A., Butrynski, J. E., Morgan, J. A., Wagner, A. J., D'Adamo, D., McMillan, A., Demetri, G. D., George, S.
Publicado no Ann Oncol (2014)

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy

Por Penel, N., Demetri, G. D., Blay, J. Y., Cousin, S., Maki, R. G., Chawla, S. P., Judson, I., von Mehren, M., Schöffski, P., Verweij, J., Casali, P., Rodenhuis, S., Schütte, H. J., Cassar, A., Gomez, J., Nieto, A., Zintl, P., Pontes, M. J., Le Cesne, A.
Publicado no Ann Oncol (2013)